Vascular intervention studies generally consider patency and limb salvage as primary outcomes. However, quality of life is increasingly considered an important patient-oriented outcome measurement of vascular interventions. Existing literature was analyzed to determine the effect of different treatments on quality of life for patients suffering from either claudication or critical limb ischemia.
Basic methods
A review of the literature was undertaken in the Medline library. A search was performed on quality of life in peripheral arterial disease. Results were stratified according to treatment groups.
Principal findings
Twenty-one articles described quality of life in approximately 4600 patients suffering from peripheral arterial disease. Invasive treatment generally results in better quality of life scores (at a maximum of 2 years of follow-up), compared with non-invasive treatment. In patients with critical limb ischemia, successful revascularization improves quality of life scores. Only one study reported long-term results.
Conclusions
Increase in quality of life scores can be found for any intervention performed for peripheral arterial disease. However, there is scarce information on long-term quality of life after vascular intervention.
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463–e654.
2.
Rooke TW, Hirsch AT, Misra S, et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2020–2045.
3.
SelvinEErlingerTP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation2004; 110: 738–743.
4.
NorgrenLHiattWRDormandyJA. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg200733 (Suppl 1): S1–S75.
5.
RutherfordRBBakerJDErnstC. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg1997; 26: 517–538.
6.
CzajkowskiSM. Health-related quality of life outcomes in clinical research: NHLBI policy and perspectives. Ann Thorac Surg1998; 66: 1486–1487.
7.
SaxenaSOrleyJ. Quality of life assessment: the world health organization perspective. Eur Psychiatry1997; 12S3: 263s–266s.
8.
BreekJCde VriesJvan HeckGL. Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life. J Vasc Surg2005; 41: 443–450.
9.
CurrieICWilsonYGBairdRN. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg1995; 10: 356–361.
10.
KhairaHSHangerRShearmanCP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg1996; 11: 65–69.
11.
BreekJCHammingJFDe VriesJ. The impact of walking impairment, cardiovascular risk factors, and comorbidity on quality of life in patients with intermittent claudication. J Vasc Surg2002; 36: 94–99.
12.
LetterstalAForsbergCOlofssonP. Risk attitudes to treatment among patients with severe intermittent claudication. J Vasc Surg2008; 47: 988–994.
13.
NicolaiSPTeijinkJAPrinsMH. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg2010; 52: 348–355.
14.
NordanstigJGelinJHensaterM. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication—a prospective randomised trial. Eur J Vasc Endovasc Surg2011; 42: 220–227.
15.
FakhryFSpronkSde RidderM. Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. Arch Phys Med Rehabil2011; 92: 1066–1073.
16.
GardnerAWKatzelLISorkinJD. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc2001; 49: 755–762.
17.
EngelhardtMBruijnenHScharmerC. Prospective 2-years follow-up quality of life study after infrageniculate bypass surgery for limb salvage: lasting improvements only in non-diabetic patients. Eur J Vasc Endovasc Surg2008; 36: 63–70.
18.
ForbesJFAdamDJBellJ. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg2010; 51(5 Suppl): 43S–51S.
19.
JohnsonBFSinghSEvansL. A prospective study of the effect of limb-threatening ischaemia and its surgical treatment on the quality of life. Eur J Vasc Endovasc Surg1997; 13: 306–314.
20.
NguyenLLMonetaGLConteMS. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg2006; 44: 977–983. discussion 83–84.
21.
SprengersRWTeraaMMollFL. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg2010; 52: 843–849, 9 e1.
22.
OzturkCte SlaaADolmansDE. Quality of life in perspective to treatment of postoperative edema after peripheral bypass surgery. Ann Vasc Surg2012; 26: 373–382.
23.
DippelEShammasNTakesV. Twelve-month results of percutaneous endovascular reconstruction for chronically occluded superficial femoral arteries: a quality-of-life assessment. J Invasive Cardiol2006; 18: 316–321.
24.
BrothersTERobisonJGElliottBM. Prospective decision analysis for peripheral vascular disease predicts future quality of life. J Vasc Surg2007; 46: 701–708. discussion 8.
25.
KalbaughCATaylorSMBlackhurstDW. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg2006; 44: 296–302. discussion 3.
26.
LongJModrallJGParkerBJ. Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease. J Vasc Surg2004; 39: 723–727.
27.
PaaskeWPLaustsenJ. Femorodistal bypass grafting: quality of life and socioeconomic aspects. Eur J Vasc Endovasc Surg1995; 10: 226–230.
28.
RemesLIsoahoRVahlbergT. Quality of life among lower extremity peripheral arterial disease patients who have undergone endovascular or surgical revascularization: a case-control study. Eur J Vasc Endovasc Surg2010; 40: 618–625.
29.
van HattumESTangelderMJLawsonJA. The quality of life in patients after peripheral bypass surgery deteriorates at long-term follow-up. J Vasc Surg2011; 53: 643–650.
30.
WohlgemuthWASafonovaOEngelhardtM. Improvement of the quality of life concerning the health of patients with peripheral arterial disease (PAD) after successful bypass surgery. Vasa2008; 37: 338–344.
31.
EgbergLMattiassonACLjungstromKG. Health-related quality of life in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty: a prospective one-year follow-up. J Vasc Nurs2010; 28: 72–77.
32.
BoschJLvan der GraafYHuninkMG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation1999; 99: 3155–3160.
33.
RemesLIsoahoRVahlbergT. Quality of life three years after major lower extremity amputation due to peripheral arterial disease. Aging Clin Exp Res2010; 22(5–6): 395–405.
